New York Ventures
Signal active
Investment Firm
Overview
New York Ventures is dedicated to encouraging innovation and fueling economic growth in communities across the State. This venture capital investment arm of Empire State Development is one of New York State's business resources and innovation investments, including the Governor's START-UP NY program, Innovation Hot Spots, the Regional Economic Development Councils, the Centers of Advanced Technology and Centers of Excellence networks, and the SUNY 2020 Initiative.
Highlights
Founded
2015
Industry
Employees
1-10
Investment
138
Lead Investment
6
Exits
7
Stages
Early Stage Venture, Seed
Investor Type
Venture Capital
Location
New York, New York, United States, North America
Contact Information
Social
Profile Resume
New York Ventures, established in 2015 and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture, Seed investments across Information Technology, Software, Health Care, Financial Services, Venture Capital, Finance, Impact Investing, Hedge Funds, Medical, Social CRM. The organization boasts a portfolio of 137 investments, with an average round size of $9.4M and 7 successful exits. Their recent investments include Cureatr, Activate Venture Partners, JMI Equity, Deerfield, Cardinal Partners. The highest investment round they participated in was $59.4B. Among their most notable exits are Cureatr and Activate Venture Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
New York Ventures has made 138 investments. Their most recent investment was on Jul 11, 2024, when Cell BioEngines raised $250.0K.
New York Ventures has made 79 diversity investments. Their most recent diversity investment was on Jun 07, 2023, when Yuvo Health raised $20.2M.
investments
138
Diversity investments
79
Lead investments
6
Number of exits
7
Investments
138
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Aug 11, 2023 | ZetaGen Therapeutics | Health Care | 9.8M |
| Dec 12, 2023 | Dimensional Energy | Energy | 20.0M |
| May 24, 2024 | ZeroMark | Augmented Reality | 7.0M |
| Jul 11, 2024 | Cell BioEngines | Biotechnology | 250.0K |
Exits
7
Funding Timeline
Funding rounds
138
Investors
0
Funds
0
Funding Rounds
138
New York Ventures has raised 138 rounds. Their latest funding was raised on Jul 11, 2024 from a Pre Seed Round - Cell BioEngines round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Aug 11, 2023 | Series B - ZetaGen Therapeutics | - | 9.8M | - |
| Dec 12, 2023 | Series A - Dimensional Energy | - | 20.0M | - |
| May 24, 2024 | Seed Round - ZeroMark | - | 7.0M | - |
| Jul 11, 2024 | Pre Seed Round - Cell BioEngines | - | 250.0K | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.